RecruitingNCT03291652
Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential
Sponsor
Chinese University of Hong Kong
Enrollment
140 participants
Start Date
Feb 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).
Eligibility
Min Age: 30 YearsMax Age: 85 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying DSA/3DRA for people with atheroscleroses, cerebral and ischemic stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 85 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTDSA/3DRA
DSA/3DRA
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03291652
Related Trials
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
NCT0597668530 locations
STROKE 120 ACTION Trial
NCT071353101 location
Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
NCT077135372 locations
Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke
NCT074057622 locations
Quantitative Net Water Uptake as a Predictor of Functional Outcomes After Intravenous Thrombolysis in Acute Ischemic Stroke International Multicenter Observational Retrospective Study
NCT072999811 location